Chronic Bronchitis
Long-term bronchial tube inflammation causing persistent cough.
TL;DR
A productive cough most days for 3+ months in 2 consecutive years — usually driven by smoking (as part of COPD) — with mucus hypersecretion, breathlessness on exertion, and a real risk of progressive lung damage without smoking cessation.
Overview
Chronic bronchitis is defined clinically: cough with sputum production on most days for at least 3 months in 2 consecutive years. It is one of the two faces of COPD (alongside emphysema), and cigarette smoke causes the overwhelming majority of cases, with air pollution, occupational dusts, and biomass fuel exposure contributing. The pathology is airway inflammation and mucus-gland enlargement: inflamed, narrowed bronchi produce excess mucus that the damaged clearance system cannot move, driving the daily cough. Beyond the cough, patients develop exertional breathlessness, frequent chest infections, and gradual decline in lung function. The single intervention that changes the trajectory is quitting smoking; bronchodilators, inhaled steroids in selected patients, pulmonary rehabilitation, and vaccinations manage the rest.
Common Symptoms
- •Daily productive cough — mucus most mornings, most days, for months
- •Sputum that is white/clear at baseline, turning yellow-green during exacerbations
- •Progressive breathlessness on exertion
- •Wheeze and chest congestion
- •Frequent chest infections (exacerbations) with worse cough, more sputum, fever
- •Fatigue and reduced exercise tolerance in advancing disease
Common Causes
- •Cigarette smoking — the dominant cause (~80–90% of COPD)
- •Occupational dusts and fumes (coal, silica, textiles, welding)
- •Air pollution and biomass fuel smoke (indoor cooking fires)
- •Childhood respiratory infections and asthma as contributing factors
- •Alpha-1 antitrypsin deficiency in a small minority (especially non-smokers with early disease)
Root Causes
Smoking cessation is the only intervention proven to slow the decline in lung function — nothing else comes close. Beyond that: remove occupational exposures, get pulmonary rehabilitation (strong evidence for breathlessness and quality of life), stay vaccinated (flu, pneumococcal, COVID), and treat exacerbations early since each one accelerates decline.
How It's Diagnosed
Diagnostic Markers
- Clinical definition: productive cough ≥3 months/year for 2 consecutive years
- Spirometry: post-bronchodilator FEV1/FVC <0.70 confirms COPD
- Chest imaging to exclude other causes
- Sputum culture during exacerbations when infection is suspected
- Alpha-1 antitrypsin level in young or non-smoking cases
When to See a Doctor
Anyone with a daily productive cough lasting months should get spirometry — early COPD is underdiagnosed. Seek prompt care for exacerbations (increased breathlessness, changed sputum, fever), and emergency care for severe breathlessness, confusion, or bluish lips.
Supplements Studied For This
Diet & Lifestyle
Suggested Pattern
No diet reverses chronic bronchitis. Maintaining muscle mass matters — COPD-related weight loss and muscle wasting worsen outcomes, so adequate protein and calories are therapeutic. Antioxidant-rich diets are associated with better lung function in observational data. Some patients find heavy carbohydrate loads worsen breathlessness (CO2 production).
Eat more
- Adequate protein (1–1.2 g/kg/day) — muscle preservation is outcome-relevant in COPD
- Fruits and vegetables — antioxidant intake correlates with better lung function
- Oily fish — omega-3s for the inflammatory background
- Smaller, more frequent meals if large meals worsen breathlessness
Avoid
- Nothing therapeutic to avoid specifically — but undernutrition is the real danger
- Excess alcohol (immune suppression, nutritional displacement)
- Very large meals that distend the stomach and restrict the diaphragm
Supporting Research
Effect of N-acetylcysteine on chronic bronchitis exacerbations: a systematic review and meta-analysis
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
Frequently Asked Questions
Who It Affects
Chronic bronchitis affects roughly 3–7% of adults, rising steeply with smoking history and age. COPD overall affects ~10% of adults over 40 worldwide and is a leading cause of death.
Adults over 40 with significant smoking history; occupational exposure adds risk in trades and industry. Increasingly recognized in never-smokers with biomass or pollution exposure, particularly women in low-income countries.
Quick Facts
- •Definition: productive cough 3+ months/year, 2 years running
- •Smoking causes ~85% — quitting is the only disease-modifying step
- •Spirometry confirms the diagnosis and stages severity
- •Each exacerbation accelerates lung decline — treat early
Lifestyle Tips
- •Quit smoking — the only intervention that changes the trajectory; pharmacotherapy doubles quit rates
- •Pulmonary rehabilitation: supervised exercise and education with strong quality-of-life evidence
- •Pursed-lip breathing for breathlessness episodes
- •Get flu, pneumococcal, and COVID vaccinations — infections drive decline
- •Treat exacerbations early per your action plan; do not tough them out
- •Review inhaler technique at every visit — most people use them wrong
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.